EpiVax (United States)

Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”

Anne S. De Groot, Leonard Moise, Julie A. McMurry et al. · Blood · 2008 · 383 citations · Full text

Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein

Eugen Koren, Anne S. De Groot, Vibha Jawa et al. · Clinical Immunology · 2007 · 141 citations

Immunodeficiencies, Immunology, Pathology +8

T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020

Vibha Jawa, Frances Terry, Jochem Gokemeijer et al. · Frontiers in Immunology · 2020 · 129 citations · Full text

iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines

Leonard Moise, Andrés H. Gutiérrez, Farzana Kibria et al. · Human Vaccines & Immunotherapeutics · 2015 · 115 citations · Full text

Immunology, Immunodominance, Immunotherapy +18

A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)

M. P. Bogryantseva, Svetlana Usova, Oleg V. Pyankov et al. · Russian Journal of Infection and Immunity · 2021 · 109 citations · Full text

Immunodeficiencies, Peptide-based Epivaccorona Vaccine, Immunology +21